OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- Product NDC
- 67877-451
- 11-digit product format
- 678770451
- Labeler code
- 67877
- Product ID
- 67877-451_b9b67a37-65d5-47fb-a417-0e8901f27f22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA207037
- Marketing category
- ANDA
- Marketing start
- 2025-05-01
- Substance
- OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
- Active strength
- 40; 25 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207037-001 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | |
| A207037-002 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | |
| A207037-003 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207037-001 | AB |
| A207037-002 | AB |
| A207037-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207037-001 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A207037-002 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A207037-003 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A207037-001 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207037-002 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207037-003 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207037-001 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207037-002 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207037-003 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207037-001 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207037-002 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207037-003 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207037-001 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207037-002 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207037-003 | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET / ORAL | AB | 2024-07-11 | 79d66fd596c7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A207037-001 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG | TABLET / ORAL | AB | 2024-07-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207037-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A207037-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A207037-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A207037-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207037-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207037-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207037-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207037-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207037-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207037-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207037-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207037-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207037-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207037-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207037-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207037-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207037-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207037-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207037-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207037-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207037-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207037-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207037-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207037-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207037-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207037-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207037-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207037-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207037-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207037-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207037-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207037-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207037-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207037-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207037-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207037-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207037-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207037-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207037-003 | AB | 1 | 79d66fd596c7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A207037-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OLMESARTAN MEDOXOMIL | 40 mg/1 |
| HYDROCHLOROTHIAZIDE | 25 mg/1 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67877-451-30 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 5 | |
| 67877-451-90 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67877-451-30 | EA - Each | 67877-451 | 3f493b4b-c38d-493c-86de-2d0f95a08e34 | 1 | 2025-05-14 |
| 67877-451-90 | EA - Each | 67877-451 | c46411f4-0f0e-4dd6-92fc-95f40f752e7e | 1 | 2025-05-14 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 403855 | olmesartan medoxomil 40 MG / hydroCHLOROthiazide 25 MG Oral Tablet | PSN | 9c68d45d-e4c8-4f6f-9ca5-faadc056e6e7 | 1 |
| 403855 | hydrochlorothiazide 25 MG / olmesartan medoxomil 40 MG Oral Tablet | SCD | 9c68d45d-e4c8-4f6f-9ca5-faadc056e6e7 | 1 |
| 403855 | HCTZ 25 MG / olmesartan medoxomil 40 MG Oral Tablet | SY | 9c68d45d-e4c8-4f6f-9ca5-faadc056e6e7 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 67877-451-30 | 67877045130 | 30 TABLET, FILM COATED in 1 BOTTLE (67877-451-30) | 2025-05-01 | No | No | Current |
| 67877-451-90 | 67877045190 | 90 TABLET, FILM COATED in 1 BOTTLE (67877-451-90) | 2025-05-01 | No | No | Current |